These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9071570)
1. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Laake K; Odegård A; Andersen TI; Bukholm IK; Kåresen R; Nesland JM; Ottestad L; Shiloh Y; Børresen-Dale AL Genes Chromosomes Cancer; 1997 Mar; 18(3):175-80. PubMed ID: 9071570 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867 [TBL] [Abstract][Full Text] [Related]
3. ATM mutations in cancer families. Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579 [TBL] [Abstract][Full Text] [Related]
4. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer. Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Kerangueven F; Eisinger F; Noguchi T; Allione F; Wargniez V; Eng C; Padberg G; Theillet C; Jacquemier J; Longy M; Sobol H; Birnbaum D Oncogene; 1997 Jan; 14(3):339-47. PubMed ID: 9018120 [TBL] [Abstract][Full Text] [Related]
6. Allelic imbalance at chromosome region 11q23 in cervical carcinomas. Skomedal H; Helland A; Kristensen GB; Holm R; Børresen-Dale AL Eur J Cancer; 1999 Apr; 35(4):659-63. PubMed ID: 10492643 [TBL] [Abstract][Full Text] [Related]
7. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases. Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440 [TBL] [Abstract][Full Text] [Related]
8. A frequent polymorphism of the gene mutated in ataxia telangiectasia. Dörk T; Westermann S; Dittrich O; Twardowski M; Karstens JH; Schmidtke J; Stuhrmann M Mol Cell Probes; 1997 Feb; 11(1):71-3. PubMed ID: 9076718 [TBL] [Abstract][Full Text] [Related]
9. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas. Waha A; Sturne C; Kessler A; Koch A; Kreyer E; Fimmers R; Wiestler OD; von Deimling A; Krebs D; Schmutzler RK Int J Cancer; 1998 Oct; 78(3):306-9. PubMed ID: 9766563 [TBL] [Abstract][Full Text] [Related]
10. Genomic organization of the ATM locus involved in ataxia-telangiectasia. Rasio D; Negrini M; Croce CM Cancer Res; 1995 Dec; 55(24):6053-7. PubMed ID: 8521392 [TBL] [Abstract][Full Text] [Related]
11. ATM gene deletion in patients with adult acute lymphoblastic leukemia. Haidar MA; Kantarjian H; Manshouri T; Chang CY; O'Brien S; Freireich E; Keating M; Albitar M Cancer; 2000 Mar; 88(5):1057-62. PubMed ID: 10699895 [TBL] [Abstract][Full Text] [Related]
12. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Koreth J; Bakkenist CJ; McGee JO Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840 [TBL] [Abstract][Full Text] [Related]
13. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Man S; Ellis IO; Sibbering M; Blamey RW; Brook JD Cancer Res; 1996 Dec; 56(23):5484-9. PubMed ID: 8968105 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 11q22-q23 in breast cancer. Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477 [TBL] [Abstract][Full Text] [Related]
15. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416 [TBL] [Abstract][Full Text] [Related]
17. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Hall J Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413 [TBL] [Abstract][Full Text] [Related]
18. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634 [TBL] [Abstract][Full Text] [Related]
19. Contribution of mutations in ATM to breast cancer development in the Czech population. Soukupova J; Dundr P; Kleibl Z; Pohlreich P Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957 [TBL] [Abstract][Full Text] [Related]
20. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer. Bebb DG; Yu Z; Chen J; Telatar M; Gelmon K; Phillips N; Gatti RA; Glickman BW Br J Cancer; 1999 Aug; 80(12):1979-81. PubMed ID: 10471049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]